about
Introduction to Cardiovascular Magnetic Resonance: Technical Principles and Clinical ApplicationsMyocardial Regional Interstitial Fibrosis is Associated With Left Intra-Ventricular Dyssynchrony in Patients With Heart Failure: A Cardiovascular Magnetic Resonance Study.Diffusion tensor magnetic resonance imaging mapping the fiber architecture remodeling in human myocardium after infarction: correlation with viability and wall motion.Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models.Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices.Endocardial Remodeling in Heart Failure Patients with Impaired and Preserved Left Ventricular Systolic Function--A Magnetic Resonance Image StudyRenal perfusion 3-T MR imaging: a comparative study of arterial spin labeling and dynamic contrast-enhanced techniques.Pericardial fat is associated with ventricular tachyarrhythmia and mortality in patients with systolic heart failure.The extent of edema and tumor synchronous invasion into the subventricular zone and corpus callosum classify outcomes and radiotherapy strategies of glioblastomas.Left ventricular regional myocardial motion and twist function in repaired tetralogy of Fallot evaluated by magnetic resonance tissue phase mapping.Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients.Clinical feasibility of Gd-EOB-DTPA-enhanced MR imaging for assessing liver function: validation with ICG tests and parenchymal cell volume.Improvement of Cerebral Glucose Metabolism in Symptomatic Patients With Carotid Artery Stenosis After Stenting.CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction.Effect of cardiac rehabilitation on angiogenic cytokines in postinfarction patients.Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.Perfusion of residual viable myocardium in nontransmural infarct zone after intervention: MR quantitative myocardial blood flow measurementCirculating biomarkers of collagen type I metabolism mark the right ventricular fibrosis and adverse markers of clinical outcome in adults with repaired tetralogy of FallotCombination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction PatientsMRI evaluation of the adaptive response of the contralateral kidney following nephrectomy in patients with renal cell carcinomaFunctional mitral regurgitation in chronic ischemic coronary artery disease: analysis of geometric alterations of mitral apparatus with magnetic resonance imagingEffect of cardiac rehabilitation on myocardial perfusion reserve in postinfarction patientsMitral tetrahedron as a geometrical surrogate for chronic ischemic mitral regurgitationExercise training increases myocardial perfusion in residual viable myocardium within infarct zoneSequential changes of myocardial microstructure in patients postmyocardial infarction by diffusion-tensor cardiac MR: correlation with left ventricular structure and functionCMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEFEmpirical Mode Decomposition and Monogenic Signal-Based Approach for Quantification of Myocardial Infarction From MR ImagesEffect of Empagliflozin on Cardiac Function, Adiposity, and Diffuse Fibrosis in Patients with Type 2 Diabetes Mellitus
P50
Q26749269-3863CA0D-5D6A-4F70-88CB-E87E59EBB7E3Q30391425-8CADC26D-77C8-4F63-AD19-CED37B06B60FQ31057719-1CBCD37E-D31D-43FB-B8F6-5DAFDD7FDEE0Q35086172-12417553-6975-4304-87C7-0A055E4B3C79Q36297961-90043AC7-E565-47AE-A9D2-89B2C5517A76Q36579775-48373D3A-36C1-4B37-B093-68883B626C2AQ37957830-21DCD78E-411F-4F96-9075-F7A18B5F0E49Q41636439-714DBB42-5AD9-49B5-8290-8792EBDC5A36Q47423694-504B81BD-6E0E-450D-83E9-FDE20662B5FCQ47836822-7FA8BAA4-E32A-4CA0-A354-B6ABA5504F97Q47887543-3B55C12F-57D9-4D48-8392-591FFC26AB47Q50225614-AF5A6AB1-12B2-44D6-93BF-EBC1CCF20968Q50579245-E222BD12-B826-4E2D-B1C0-E567D6738D60Q51724009-E3298B80-9479-41BC-BBF6-EC0EF62774D8Q51756032-34357290-39C8-4CBC-B3D5-77FB8D76EFBDQ54600684-996D671B-9C79-4A9A-B92F-0C7D26B036DCQ56783302-A866742B-833B-4E7A-A6E4-2AA99B7F6690Q58329063-93AADFFB-E47F-4A04-AB57-1341ED7AC349Q58582767-0460E951-5BF6-47D3-83E2-C2F0381FE30AQ59187126-977BAE52-C3A2-435B-ABB0-34FF385E2CCBQ80805618-B2ACAEFB-AE4D-4C0E-A0F9-69346365B868Q81252881-DA4465A9-A99D-4C29-A3FD-AE744FD46074Q81702439-1C40D658-FCE1-4746-8208-ACEDB3A92817Q84184723-0FA01F33-C2E5-4F8D-B470-9D20A2C3B6D1Q84647845-3BC40C50-B287-46DE-9F5B-580C600C8090Q85346949-9A3B9278-F00D-4C03-B0B1-1D6BCE26A38AQ89557787-25428359-3787-48F3-8801-01097C732F70Q90950755-F05D6CA6-0522-49FE-8129-9E4E4348DBF9
P50
description
researcher ORCID ID = 0000-0002-6699-2298
@en
wetenschapper
@nl
name
Mao-Yuan Su
@ast
Mao-Yuan Su
@en
Mao-Yuan Su
@es
Mao-Yuan Su
@nl
type
label
Mao-Yuan Su
@ast
Mao-Yuan Su
@en
Mao-Yuan Su
@es
Mao-Yuan Su
@nl
prefLabel
Mao-Yuan Su
@ast
Mao-Yuan Su
@en
Mao-Yuan Su
@es
Mao-Yuan Su
@nl
P106
P1153
36606961000
P31
P496
0000-0002-6699-2298